Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
5
×
boston blog main
life sciences
national blog main
biotech
avapritinib
blueprint medicines
boston top stories
clinical trials
deals
national top stories
roche
san francisco blog main
cancer
eli lilly
europe blog main
europe top stories
fda
genentech
investing
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
san francisco top stories
selpercatinib
thyroid cancer
akouos
andrew berens
astellas pharmaceuticals
biopharma
california institute for biomedical research
cancer drugs
capmatinib
cstone pharmaceuticals
decibel therapeutics
deciphera pharmaceuticals
duchenne
european medicines agency
fisogatinib
flatiron health
What
fda
5
×
approval
drug
blueprint
cancer
medicines
medicine
plans
ret
roche
therapeutics
therapy
address
affects
americans
announced
approved
approves
betting
billion
biopharma
candidate
carries
certain
chasing
currently
date
deadly
deal
deciphera
designed
developing
duchenne
filing
forms
frequency
gene
genetic
gi
hearing
Language
unset
5
×
Current search:
boston
×
unset
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug